Pharmacological Interventions

Children's drug use in Africa is a growing concern that requires urgent attention and comprehensive strategies. Understanding the complex factors influencing children's drug use and implementing effective prevention and intervention...

Children's drug use in Africa is a growing concern that requires urgent attention and comprehensive strategies. Understanding the complex factors influencing children's drug use and implementing effective prevention and intervention...

ISSUP presents its webinar on Interventions in Substance Use Disorders (SUD) with experts from Uruguay: A view from Psychology and Neuroscience.

ISSUP Indonesia, ISSUP Malaysia and ISSUP Philippines, in collaboration with ITTC, present its joint webinar series on the use of Amphetamine-type stimulants (ATS) in the Asian region. This is Part I of a three-part webinar series on Stimulant Use

About the webinar: This seminar provided an overview of Liam’s PhD studies, beginning with a systematic review and meta-analysis of previously researched pharmacological treatments for methamphetamine withdrawal. It then proposed a novel...

Abstract Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown. Objective To study...

Abstract Psychedelics produce fast and persistent antidepressant effects and induce neuroplasticity resembling the effects of clinically approved antidepressants. We recently reported that pharmacologically diverse antidepressants...

For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...

For Immediate Release: May 24, 2023 Today, the U.S. Food and Drug Administration (FDA) approved the extended-release Brixadi (buprenorphine) subcutaneous (for use under the skin) injection to treat moderate to severe opioid use disorder...